Search

Deborah Crouch

Examiner (ID: 4504, Phone: (571)272-0727 , Office: P/1632 )

Most Active Art Unit
1632
Art Unit(s)
1804, 1819, 2899, 1632, 3725
Total Applications
1439
Issued Applications
694
Pending Applications
237
Abandoned Applications
511

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6024222 [patent_doc_number] => 20110052548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'CELL CULTURE MEDIA TO DIFFERENTIATE EMBRYONIC STEM CELLS INTO NEURONAL LINEAGES' [patent_app_type] => utility [patent_app_number] => 12/869599 [patent_app_country] => US [patent_app_date] => 2010-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9338 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052548.pdf [firstpage_image] =>[orig_patent_app_number] => 12869599 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/869599
CELL CULTURE MEDIA TO DIFFERENTIATE EMBRYONIC STEM CELLS INTO NEURONAL LINEAGES Aug 25, 2010 Abandoned
Array ( [id] => 5929374 [patent_doc_number] => 20110039333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'DEFINED CONDITIONS FOR HUMAN EMBRYONIC STEM CELL CULTURE AND PASSAGE' [patent_app_type] => utility [patent_app_number] => 12/855578 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7245 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039333.pdf [firstpage_image] =>[orig_patent_app_number] => 12855578 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/855578
DEFINED CONDITIONS FOR HUMAN EMBRYONIC STEM CELL CULTURE AND PASSAGE Aug 11, 2010 Abandoned
Array ( [id] => 5954495 [patent_doc_number] => 20110034536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'CONTROLLING THE POTENTIAL OF PRIMATE NEURAL STEM CELLS BY REGULATING PAX6' [patent_app_type] => utility [patent_app_number] => 12/849249 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 14346 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034536.pdf [firstpage_image] =>[orig_patent_app_number] => 12849249 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/849249
Production of primate neural stem cells through expression of pax6 Aug 2, 2010 Issued
Array ( [id] => 6198320 [patent_doc_number] => 20110030078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'TRYPANOSOME RESISTANT NON-HUMAN TRANSGENIC ANIMAL' [patent_app_type] => utility [patent_app_number] => 12/848738 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20384 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20110030078.pdf [firstpage_image] =>[orig_patent_app_number] => 12848738 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/848738
TRYPANOSOME RESISTANT NON-HUMAN TRANSGENIC ANIMAL Aug 1, 2010 Abandoned
Array ( [id] => 6196123 [patent_doc_number] => 20110027881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'PRODUCTION METHOD OF IMMUNE CELLS' [patent_app_type] => utility [patent_app_number] => 12/845178 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 4648 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027881.pdf [firstpage_image] =>[orig_patent_app_number] => 12845178 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/845178
PRODUCTION METHOD OF IMMUNE CELLS Jul 27, 2010 Abandoned
Array ( [id] => 6154791 [patent_doc_number] => 20110023142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Genetically Modified Rat Models for Cytokine-Cytokine Signaling Pathways' [patent_app_type] => utility [patent_app_number] => 12/842418 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22751 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20110023142.pdf [firstpage_image] =>[orig_patent_app_number] => 12842418 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/842418
Genetically modified rat comprising a cytokine gene disruption and exhibiting a greater susceptibility to a cytokine-mediated autoimmune and/or inflammatory disease Jul 22, 2010 Issued
Array ( [id] => 6014916 [patent_doc_number] => 20110223189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'AGENT FOR TREATING LEISHMANIA INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/841713 [patent_app_country] => US [patent_app_date] => 2010-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9212 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223189.pdf [firstpage_image] =>[orig_patent_app_number] => 12841713 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/841713
DNA expression constructs encoding the Leishmania infantum antigens thiol-specific antioxidant protein and kinetoplastid membrane protein Jul 21, 2010 Issued
Array ( [id] => 11389740 [patent_doc_number] => 09550975 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-24 [patent_title] => 'SSEA-3 pluripotent stem cell isolated from body tissue' [patent_app_type] => utility [patent_app_number] => 12/836264 [patent_app_country] => US [patent_app_date] => 2010-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 23038 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12836264 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/836264
SSEA-3 pluripotent stem cell isolated from body tissue Jul 13, 2010 Issued
Array ( [id] => 5933326 [patent_doc_number] => 20110041191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'Animal model, and products and methods useful for the production thereof' [patent_app_type] => utility [patent_app_number] => 12/833474 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 73 [patent_figures_cnt] => 73 [patent_no_of_words] => 18958 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20110041191.pdf [firstpage_image] =>[orig_patent_app_number] => 12833474 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/833474
Animal model, and products and methods useful for the production thereof Jul 8, 2010 Abandoned
Array ( [id] => 8410171 [patent_doc_number] => 08273569 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Preparation of human embryonic stem cells' [patent_app_type] => utility [patent_app_number] => 12/822004 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 21 [patent_no_of_words] => 10151 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12822004 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/822004
Preparation of human embryonic stem cells Jun 22, 2010 Issued
Array ( [id] => 6024273 [patent_doc_number] => 20110052599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Facilitation of Oocyte, Zygote and Pre-Implantation Embryo Maturation' [patent_app_type] => utility [patent_app_number] => 12/818055 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15987 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052599.pdf [firstpage_image] =>[orig_patent_app_number] => 12818055 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/818055
In vitro exposure of immature oocytes to BDNF enhances generation of embryonic stem cells Jun 16, 2010 Issued
Array ( [id] => 9026363 [patent_doc_number] => 08535944 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Culturing embryonic stem cells, embryonic stem-like cells, or induced pluripotent stem cells with a Muc1 or Muc1* ligand' [patent_app_type] => utility [patent_app_number] => 12/814420 [patent_app_country] => US [patent_app_date] => 2010-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 18468 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12814420 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/814420
Culturing embryonic stem cells, embryonic stem-like cells, or induced pluripotent stem cells with a Muc1 or Muc1* ligand Jun 10, 2010 Issued
Array ( [id] => 6348967 [patent_doc_number] => 20100248989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/789908 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 47854 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20100248989.pdf [firstpage_image] =>[orig_patent_app_number] => 12789908 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/789908
Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells May 27, 2010 Abandoned
Array ( [id] => 6588697 [patent_doc_number] => 20100291576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'IMPRINTED GENES AS EPIGENETIC MARKERS FOR USE IN CLONING AND REGENERATIVE CELL PROCEDURES' [patent_app_type] => utility [patent_app_number] => 12/782245 [patent_app_country] => US [patent_app_date] => 2010-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15729 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291576.pdf [firstpage_image] =>[orig_patent_app_number] => 12782245 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/782245
IMPRINTED GENES AS EPIGENETIC MARKERS FOR USE IN CLONING AND REGENERATIVE CELL PROCEDURES May 17, 2010 Abandoned
Array ( [id] => 5982576 [patent_doc_number] => 20110072526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'PROCESS FOR PRODUCING EXOGENOUS PROTEIN IN THE MILK OF TRANSGENIC MAMMALS AND A PROCESS FOR PURIFYING PROTEINS THEREFROM' [patent_app_type] => utility [patent_app_number] => 12/781500 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13007 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20110072526.pdf [firstpage_image] =>[orig_patent_app_number] => 12781500 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/781500
PROCESS FOR PRODUCING EXOGENOUS PROTEIN IN THE MILK OF TRANSGENIC MAMMALS AND A PROCESS FOR PURIFYING PROTEINS THEREFROM May 16, 2010 Abandoned
Array ( [id] => 9046425 [patent_doc_number] => 08540978 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => 'Treatment composition comprising physically disrupted tooth pulp and non-cultured stem cells in a matrix' [patent_app_type] => utility [patent_app_number] => 12/772363 [patent_app_country] => US [patent_app_date] => 2010-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 27 [patent_no_of_words] => 21064 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12772363 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/772363
Treatment composition comprising physically disrupted tooth pulp and non-cultured stem cells in a matrix May 2, 2010 Issued
Array ( [id] => 6492951 [patent_doc_number] => 20100209387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'ENHANCED MEDICAL IMPLANT' [patent_app_type] => utility [patent_app_number] => 12/772372 [patent_app_country] => US [patent_app_date] => 2010-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21054 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209387.pdf [firstpage_image] =>[orig_patent_app_number] => 12772372 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/772372
Enhanced medical implant comprising disrupted tooth pulp and tooth particles May 2, 2010 Issued
Array ( [id] => 9099097 [patent_doc_number] => 08562969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Treatment composition comprising physically disrupted tooth pulp and non-cultured stem cells' [patent_app_type] => utility [patent_app_number] => 12/772286 [patent_app_country] => US [patent_app_date] => 2010-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 28 [patent_no_of_words] => 21065 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12772286 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/772286
Treatment composition comprising physically disrupted tooth pulp and non-cultured stem cells May 2, 2010 Issued
Array ( [id] => 9469333 [patent_doc_number] => 08722964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-13 [patent_title] => 'Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes' [patent_app_type] => utility [patent_app_number] => 12/766284 [patent_app_country] => US [patent_app_date] => 2010-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 27380 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12766284 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/766284
Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes Apr 22, 2010 Issued
Array ( [id] => 6527850 [patent_doc_number] => 20100203633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Culture System for Rapid Expansion of Human Embryonic Stem Cells' [patent_app_type] => utility [patent_app_number] => 12/763884 [patent_app_country] => US [patent_app_date] => 2010-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15091 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203633.pdf [firstpage_image] =>[orig_patent_app_number] => 12763884 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/763884
Micro-carrier culture system for rapid expansion of human embryonic stem cells Apr 19, 2010 Issued
Menu